Home / Companies / Halo Pharmaceutical, Inc. D/B/A Cambrex Whippany

Halo Pharmaceutical, Inc. D/B/A Cambrex Whippany FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

Latest inspection NAI · Dec 8, 2025
No warning letters matched by name

Inspections 13

0 OAI

Recalls 0 0 Class I

Warning letters 0 None on file

510(k) clearances 0 None on file

Halo Pharmaceutical, Inc. D/B/A Cambrex Whippany has 0 FDA recalls, 13 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Halo Pharmaceutical, Inc. D/B/A Cambrex Whippany" is on file.

What these totals cover: FDA records filed under the name "Halo Pharmaceutical, Inc. D/B/A Cambrex Whippany".

Latest inspection: Dec 8, 2025 · NAI

Summary

Record counts and when each FDA source was last refreshed
Records	Count	Last refreshed	Source as of	Status
Recalls	0	Nov 8, 2026	File dated Nov 3, 2026	Current
510(k) clearances	0	Nov 8, 2026	File dated Nov 2, 2026	Current
Inspections	13	Nov 14, 2026	Newest record Nov 5, 2026	Current
Compliance actions	0	Nov 2, 2026	Newest record Oct 29, 2026	Current

FDA record by year

Halo Pharmaceutical, Inc. D/B/A Cambrex Whippany's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Halo Pharmaceutical, Inc. D/B/A Cambrex Whippany: FDA inspections per year

Year	Inspections	OAI	Warning letters	Recall records	Class I
2026	0	0	0	0	0
2025	1	0	0	0	0
2024	0	0	0	0	0
2023	1	0	0	0	0
2022	0	0	0	0	0
2021	0	0	0	0	0
2020	0	0	0	0	0
2019	1	0	0	0	0
2018	1	0	0	0	0
2017	2	0	0	0	0

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Halo Pharmaceutical, Inc. D/B/A Cambrex Whippany as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Halo Pharmaceutical, Inc. D/B/A Cambrex Whippany yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent FDA inspections

13 inspections from Jun 10, 2009 to Dec 8, 2025.

Date	Site	Product	Classification	FEI
Dec 8, 2025	Whippany, NJ	Veterinary	No Action Indicated (NAI)	2211084
Feb 17, 2023	Whippany, NJ	Drugs	No Action Indicated (NAI)	2211084
Dec 20, 2019	Whippany, NJ	Drugs	Voluntary Action Indicated (VAI)	2211084
May 30, 2018	Whippany, NJ	Drugs	Voluntary Action Indicated (VAI)	2211084
Aug 24, 2017	Whippany, NJ	Drugs	No Action Indicated (NAI)	2211084
Mar 20, 2017	Whippany, NJ	Drugs	Voluntary Action Indicated (VAI)	2211084
May 27, 2016	Whippany, NJ	Drugs	No Action Indicated (NAI)	2211084
Apr 24, 2015	Whippany, NJ	Drugs	Voluntary Action Indicated (VAI)	2211084
May 12, 2014	Whippany, NJ	Drugs	Voluntary Action Indicated (VAI)	2211084
Nov 20, 2012	Whippany, NJ	Drugs	No Action Indicated (NAI)	2211084
Jun 21, 2011	Whippany, NJ	Drugs	No Action Indicated (NAI)	2211084
Apr 7, 2010	Whippany, NJ	Drugs	No Action Indicated (NAI)	2211084
Jun 10, 2009	Whippany, NJ	Drugs	No Action Indicated (NAI)	2211084

NAI: No objectionable conditions or practices were found during the inspection.
VAI: Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI: Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

Facility	Location	Inspections	Latest
FEI 2211084	Whippany, NJ	13	Dec 8, 2025

Halo Pharmaceutical, Inc. D/B/A Cambrex Whippany and the FDA: common questions

Has Halo Pharmaceutical, Inc. D/B/A Cambrex Whippany received an FDA warning letter?

No FDA warning letter addressed to the name "Halo Pharmaceutical, Inc. D/B/A Cambrex Whippany" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Halo Pharmaceutical, Inc. D/B/A Cambrex Whippany received an FDA Form 483?

FDA has not published a Form 483 for "Halo Pharmaceutical, Inc. D/B/A Cambrex Whippany" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Halo Pharmaceutical, Inc. D/B/A Cambrex Whippany?

The most recent FDA inspection on file ended Dec 8, 2025 at Whippany, NJ and was classified NAI. FDA has 13 inspections of Halo Pharmaceutical, Inc. D/B/A Cambrex Whippany on file.

Need more than this page shows? Ask about Halo Pharmaceutical, Inc. D/B/A Cambrex Whippany in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.